Kish Bancorp, Inc. (KISB)
OTCMKTS · Delayed Price · Currency is USD
36.50
-0.38 (-1.03%)
Aug 8, 2025, 1:28 PM EDT
Verve Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 21.3 | 17.22 | 29.74 | 20.11 | 93.76 | 129.67 | Upgrade |
Investment Securities | 166.34 | 111.03 | 134.95 | 116.74 | 121.53 | 101.85 | Upgrade |
Trading Asset Securities | - | 9.11 | 9.26 | 11.65 | 2.28 | 5.07 | Upgrade |
Mortgage-Backed Securities | - | 52.08 | 57.88 | 52.44 | 69.93 | 39.84 | Upgrade |
Total Investments | 166.34 | 172.22 | 202.08 | 180.83 | 193.74 | 146.76 | Upgrade |
Gross Loans | 1,554 | 1,424 | 1,233 | 1,024 | 878.97 | 765.73 | Upgrade |
Allowance for Loan Losses | -10.17 | -8.91 | -7.54 | -10.34 | -10.56 | -9.77 | Upgrade |
Other Adjustments to Gross Loans | - | - | - | - | -0.26 | - | Upgrade |
Net Loans | 1,543 | 1,415 | 1,225 | 1,013 | 868.15 | 755.96 | Upgrade |
Property, Plant & Equipment | 28.73 | 27.53 | 27.4 | 31.1 | 30.03 | 28.87 | Upgrade |
Goodwill | 3.51 | 3.51 | 3.56 | 3.56 | 3.56 | 3.56 | Upgrade |
Loans Held for Sale | 3.42 | 0.79 | 0.66 | 0.63 | 3.26 | 5.67 | Upgrade |
Accrued Interest Receivable | 30.47 | 0.82 | 1.11 | 14.99 | 10.35 | 12.81 | Upgrade |
Other Long-Term Assets | 37.56 | 55.37 | 52.91 | 31.06 | 29.92 | 23.31 | Upgrade |
Total Assets | 1,835 | 1,693 | 1,543 | 1,295 | 1,233 | 1,107 | Upgrade |
Interest Bearing Deposits | 1,173 | 954.95 | 868.9 | 770.26 | 746.83 | 689.47 | Upgrade |
Institutional Deposits | - | 171.76 | 128.14 | 76.89 | 78.74 | 52.7 | Upgrade |
Non-Interest Bearing Deposits | 186.11 | 171.36 | 182.04 | 189.98 | 177.08 | 135.62 | Upgrade |
Total Deposits | 1,359 | 1,298 | 1,179 | 1,037 | 1,003 | 877.8 | Upgrade |
Short-Term Borrowings | - | 206 | 194.54 | 100.33 | 67.43 | 69.36 | Upgrade |
Current Portion of Long-Term Debt | - | 3.36 | - | - | - | - | Upgrade |
Current Portion of Leases | - | 0.5 | - | - | - | - | Upgrade |
Accrued Interest Payable | 29.38 | 22.32 | 27.4 | 20.25 | 7.92 | 8.69 | Upgrade |
Long-Term Debt | 333.31 | 49 | 46.95 | 59.31 | 71.03 | 74.37 | Upgrade |
Long-Term Leases | - | 4.71 | - | 4.42 | 4.54 | 4.66 | Upgrade |
Other Long-Term Liabilities | - | 2.48 | 2.05 | 2.06 | 2.12 | 1.77 | Upgrade |
Total Liabilities | 1,721 | 1,586 | 1,450 | 1,223 | 1,156 | 1,037 | Upgrade |
Common Stock | 1.51 | 1.51 | 1.48 | 1.35 | 1.35 | 1.35 | Upgrade |
Additional Paid-In Capital | 12.62 | 12.84 | 10.89 | 2.9 | 2.89 | 2.7 | Upgrade |
Retained Earnings | 112.1 | 106.98 | 96.88 | 85.84 | 76.43 | 69.54 | Upgrade |
Treasury Stock | -0.99 | -1.6 | -2.48 | -1.98 | -1.99 | -2.62 | Upgrade |
Comprehensive Income & Other | -11.96 | -13.62 | -14 | -16.14 | -1.57 | -1.01 | Upgrade |
Shareholders' Equity | 113.28 | 106.11 | 92.77 | 71.97 | 77.1 | 69.96 | Upgrade |
Total Liabilities & Equity | 1,835 | 1,693 | 1,543 | 1,295 | 1,233 | 1,107 | Upgrade |
Total Debt | 333.31 | 263.57 | 241.5 | 164.05 | 143 | 148.39 | Upgrade |
Net Cash (Debt) | -312.01 | -237.25 | -202.26 | -132.05 | -46.71 | -13.16 | Upgrade |
Net Cash Per Share | -108.53 | -83.10 | -76.93 | -50.29 | -17.78 | -5.11 | Upgrade |
Filing Date Shares Outstanding | 2.99 | 2.97 | 2.88 | 2.64 | 2.63 | 2.6 | Upgrade |
Total Common Shares Outstanding | 2.99 | 2.97 | 2.88 | 2.64 | 2.63 | 2.6 | Upgrade |
Book Value Per Share | 37.85 | 35.73 | 32.20 | 27.27 | 29.31 | 26.88 | Upgrade |
Tangible Book Value | 109.77 | 102.6 | 89.2 | 68.41 | 73.54 | 66.4 | Upgrade |
Tangible Book Value Per Share | 36.68 | 34.55 | 30.96 | 25.92 | 27.95 | 25.51 | Upgrade |
Source: S&P Global Market Intelligence. Banks template. Financial Sources.